Zobrazeno 1 - 10
of 63
pro vyhledávání: ''
Autor:
Valérie Thiers, Aurélie Poli, Vincent Caval, François Hafezi, Morgane Lemaire, Hélène Laude, Hervé Blanc, Jean-Pierre Vartanian, Marco Vignuzzi, Danielle Perez-Bercoff, Simon Wain-Hobson, Alexis Mathian, Rodolphe Suspène, Zahir Amoura, Oliver Hunewald
Publikováno v:
Scientific Reports
Scientific Reports, 2021, 11 (1), pp.7893. ⟨10.1038/s41598-021-87024-1⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.7893. ⟨10.1038/s41598-021-87024-1⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, 2021, 11 (1), pp.7893. ⟨10.1038/s41598-021-87024-1⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.7893. ⟨10.1038/s41598-021-87024-1⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
APOBEC3 (A3) enzymes are best known for their role as antiviral restriction factors and as mutagens in cancer. Although four of them, A3A, A3B, A3F and A3G, are induced by type-1-interferon (IFN-I), their role in inflammatory conditions is unknown. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4af1f4f289097fb3d4c3b5ec3aa9755
https://doi.org/10.1038/s41598-021-87024-1
https://doi.org/10.1038/s41598-021-87024-1
Autor:
Giorgia Battipaglia, Remy Dulery, Clemence Mediavilla, Zoé Van de Wyngaert, Tounes Ledraa, Florent Malard, Annalisa Paviglianiti, Anne Banet, Eolia Brissot, Mohamad Mohty, Sandra Eder, Simona Sestili, Ramdane Belhocine, Agnes Bonin
Publikováno v:
Cytotherapy
Cytotherapy, Elsevier, 2020, 22 (8), pp.445-449. ⟨10.1016/j.jcyt.2020.03.003⟩
Cytotherapy, 2020, 22 (8), pp.445-449. ⟨10.1016/j.jcyt.2020.03.003⟩
Cytotherapy, Elsevier, 2020, 22 (8), pp.445-449. ⟨10.1016/j.jcyt.2020.03.003⟩
Cytotherapy, 2020, 22 (8), pp.445-449. ⟨10.1016/j.jcyt.2020.03.003⟩
International audience; Background aims: Corticosteroids are the standard first-line treatment for acute graft-versus-host disease (aGVHD), but they are associated with many complications, and less than half of patients have a sustained response.Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b006d52989ddca28c418d13f14589ed
https://hal.sorbonne-universite.fr/hal-03145941/document
https://hal.sorbonne-universite.fr/hal-03145941/document
Autor:
Aurélien Corneau, David Veyer, Tali Anne Szwebel, Nicolas Roche, Bruno Charbit, Darragh Duffy, Laura Barnabei, Hélène Péré, Flore Rozenberg, Nathalie Marin, Vincent Bondet, Benjamin Terrier, Pierre-Louis Tharaux, Solen Kernéis, Nader Yatim, Jeremy Boussier, Nikaïa Smith, Sarah H. Merkling, Alain Fischer, Nicolas Carlier, Frédéric Rieux-Laucat, Jean-Marc Treluyer, Camille Chenevier-Gobeaux, Paul Breillat, Rémy Gauzit, Luc Mouthon, Frédéric Pène, Jérôme Hadjadj, Caroline Morbieu, Catherine Blanc
Publikováno v:
Science
Science, 2020, Online ahead of print, pp.eabc6027. ⟨10.1126/science.abc6027⟩
Science, American Association for the Advancement of Science, 2020, Online ahead of print, pp.eabc6027. ⟨10.1126/science.abc6027⟩
Science, 2020, Online ahead of print, pp.eabc6027. ⟨10.1126/science.abc6027⟩
Science, American Association for the Advancement of Science, 2020, Online ahead of print, pp.eabc6027. ⟨10.1126/science.abc6027⟩
Interferons interfere with lung repair Interferons (IFNs) are central to antiviral immunity. Viral recognition elicits IFN production, which in turn triggers the transcription of IFN-stimulated genes (ISGs), which engage in various antiviral function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7191c4670494ed7b2ba47c93771b3a5f
https://hal-pasteur.archives-ouvertes.fr/pasteur-02900830/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-02900830/document
Autor:
Kaustav P. Shah, Javid Moslehi, Douglas B. Johnson, Haocan Song, Fei Ye, Justin M. Balko, Joe-Elie Salem
Publikováno v:
Cancer Immunology Research
Cancer Immunology Research, American Association for Cancer Research, 2020, 8 (7), pp.851-855. ⟨10.1158/2326-6066.CIR-19-0986⟩
Cancer Immunology Research, 2020, 8 (7), pp.851-855. ⟨10.1158/2326-6066.CIR-19-0986⟩
Cancer Immunol Res
Cancer Immunology Research, American Association for Cancer Research, 2020, 8 (7), pp.851-855. ⟨10.1158/2326-6066.CIR-19-0986⟩
Cancer Immunology Research, 2020, 8 (7), pp.851-855. ⟨10.1158/2326-6066.CIR-19-0986⟩
Cancer Immunol Res
Immune checkpoint inhibitors (ICI) are now routinely used in multiple cancers but may induce autoimmune-like side effects known as immune-related adverse events (irAE). Although classical autoimmune diseases have well-known risk factors, including ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df8051df7e975288586a2c82767394f
https://hal.sorbonne-universite.fr/hal-02948375
https://hal.sorbonne-universite.fr/hal-02948375
Publikováno v:
Inflammation Research
Inflammation Research, Springer Verlag, 2020, 69 (1), pp.51-62. ⟨10.1007/s00011-019-01293-1⟩
Inflammation Research, 2020, 69 (1), pp.51-62. ⟨10.1007/s00011-019-01293-1⟩
Inflammation Research, Springer Verlag, 2020, 69 (1), pp.51-62. ⟨10.1007/s00011-019-01293-1⟩
Inflammation Research, 2020, 69 (1), pp.51-62. ⟨10.1007/s00011-019-01293-1⟩
International audience; Objective and design - To determine whether inflammatory hepatocytes may constitute primary targets for ruxolitinib, a Janus kinase (JAK) inhibitor, its effects towards expression of hepatic acute-phase proteins, especially C-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57ccfc2101302322780a8dd1d001a54
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02364719
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02364719
Autor:
Charles R. M. Bangham, Sophie Sagawe, Lucy Cook, Jana Haddow, Richard Dillon, Paul Fields, Alexandra J. Marks, Aviva Witkover, Graham P. Taylor, Jocelyn Turpin, Aileen G. Rowan, Maria A Demontis, Anat Melamed
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2019, 104 (12), pp.e566-e569. ⟨10.3324/haematol.2019.219253⟩
e569
e566
Haematologica, Ferrata Storti Foundation, 2019, 104 (12), pp.e566-e569. ⟨10.3324/haematol.2019.219253⟩
e569
e566
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2a8a63dd27bcba3349916a5893c304
https://hal.inrae.fr/hal-03183799
https://hal.inrae.fr/hal-03183799
Autor:
Nathalie Barget, Benjamin Lefevre, Arnaud Chalin, Michel Samson, Laurence Amiot, Christelle Devisme
Publikováno v:
Cytokine
Cytokine, 2019, 117, pp.72-78. ⟨10.1016/j.cyto.2019.02.006⟩
Cytokine, Elsevier, 2019, 117, pp.72-78. ⟨10.1016/j.cyto.2019.02.006⟩
Cytokine, 2019, 117, pp.72-78. ⟨10.1016/j.cyto.2019.02.006⟩
Cytokine, Elsevier, 2019, 117, pp.72-78. ⟨10.1016/j.cyto.2019.02.006⟩
Background & aims The chemokines CXCL10 (interferon ϒ-inducible protein 10 [IP-10]), CXCL11 (Human interferon inducible T cell alpha chemokine [I-TAC]), and CXCL12 (stromal cell derived factor 1 [SDF-1]) contribute to cell recruitment, migration, ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d15b21172aa4b474e65534a8b8b5a75
https://univ-rennes.hal.science/hal-02061951/file/S1043466619300523.pdf
https://univ-rennes.hal.science/hal-02061951/file/S1043466619300523.pdf
Autor:
Franck Morschhauser, Hervé Tilly, Cédric Ménard, Bettina Fabiani, Roch Houot, Catherine Thieblemont, Krimo Bouabdallah, Karin Tarte, Gilles Salles, Steven Le Gouill, Guillaume Cartron
Publikováno v:
Blood
Blood, 2018, 132 (14), pp.1486-1494. ⟨10.1182/blood-2018-05-853499⟩
Blood, American Society of Hematology, 2018, 132 (14), pp.1486-1494. ⟨10.1182/blood-2018-05-853499⟩
Blood, 2018, 132 (14), pp.1486-1494. ⟨10.1182/blood-2018-05-853499⟩
Blood, American Society of Hematology, 2018, 132 (14), pp.1486-1494. ⟨10.1182/blood-2018-05-853499⟩
International audience; Obinutuzumab is a type II anti-CD20 monoclonal antibody that enhances antibody-dependent cellular cytotoxicity better than rituximab. Given promising results with lenalidomide and rituximab, this phase 1b study assessed the sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92acd7b291da4e49cfbfe70c2940282c
https://univ-rennes.hal.science/hal-01928199/document
https://univ-rennes.hal.science/hal-01928199/document
Autor:
Gandhi Damaj, Katell Le Du, J. Fleury, Jean Pierre Marolleau, Vincent Delwail, Krimo Bouabdallah, Anne Devillers, Guillaume Cartron, Pierre Soubeyran, Valérie Costes, Olivier Tournilhac, Pascal Godmer, Emmanuel Gyan, Marie C. Béné, Steven Le Gouill, Marie-Pierre Moles, Jean Philippe Vuillez, Mohamed Benchalal, Philippe Colombat, Jérôme Cornillon, Thierry Fest, Hervé Maisonneuve, Eric Deconinck, Kamel Laribi, Vanessa Szablewski, Roch Houot, Bernard Branger, Thierry Lamy, Remy Gressin, Anne Banos
Publikováno v:
Blood
Blood, 2018, 131 (2), pp.174-181. ⟨10.1182/blood-2017-07-793984⟩
Blood, American Society of Hematology, 2018, 131 (2), pp.174-181. ⟨10.1182/blood-2017-07-793984⟩
Blood, 2018, 131 (2), pp.174-181. ⟨10.1182/blood-2017-07-793984⟩
Blood, American Society of Hematology, 2018, 131 (2), pp.174-181. ⟨10.1182/blood-2017-07-793984⟩
International audience; The benefit of radiotherapy (RT) after chemotherapy in limited-stage diffuse large B-cell lymphoma (DLBCL) remains controversial. We conducted a randomized trial in patients with nonbulky limited-stage DLBCL to evaluate the be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2170d39a230f7291f1f5b2a3ce1e2be6
https://hal.science/hal-01635792/document
https://hal.science/hal-01635792/document
Autor:
Pavel Jindra, Rik Schots, Dietrich W. Beelen, Laurent Garderet, Simona Iacobelli, Stig Lenhoff, Didier Blaise, Xavier Poiré, Arnon Nagler, Dimitris Ziagkos, Charles Craddock, Per Ljungman, Patrice Chevallier, Ibrahim Yakoub-Agha, Nicolaus Kröger, Jakob Passweg, Nicolaas Schaap, Jaime Sanz, Marie Robin, Alessandro Rambaldi, Liisa Volin, Anja van Biezen, Ghulam J. Mufti, Jürgen Finke, Johan Maertens
Publikováno v:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (3), pp.507-513. ⟨10.1016/j.bbmt.2017.11.017⟩
Biology of Blood and Marrow Transplantation, 24, 507-513
Biology of Blood and Marrow Transplantation, 24, 3, pp. 507-513
Biology of Blood and Marrow Transplantation, Vol. 24, no.3, p. 507-513 (2018)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Biology of Blood and Marrow Transplantation, 24(3), 507-513
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (3), pp.507-513. ⟨10.1016/j.bbmt.2017.11.017⟩
Biology of Blood and Marrow Transplantation, 24, 507-513
Biology of Blood and Marrow Transplantation, 24, 3, pp. 507-513
Biology of Blood and Marrow Transplantation, Vol. 24, no.3, p. 507-513 (2018)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Biology of Blood and Marrow Transplantation, 24(3), 507-513
The deletion (5q) karyotype (del [5q]) in patients with myelodysplastic syndrome (MDS) is the most common karyotypic abnormality in de novo MDS. An increased number of blasts and additional karyotypic abnormalities (del [5q]+) are associated with a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e937b5827b0914384a5ee96ac58ad1
https://hal-amu.archives-ouvertes.fr/hal-02143674
https://hal-amu.archives-ouvertes.fr/hal-02143674